AJR Am J Roentgenol

1. OLUYEMI E
   Editorial Comment: An Alternate Method for Primary Breast Cancer Screening in Low-Resource Settings.
   AJR Am J Roentgenol. 2024 Nov 6. doi: 10.2214/AJR.24.32256.
   

   >> Share

   
   
2. CHIKARMANE SA
   Editorial Comment: The Role of Automated Breast Ultrasound and Teleradiology for Breast Cancer Screening-An International Perspective.
   AJR Am J Roentgenol. 2024 Nov 6. doi: 10.2214/AJR.24.32287.
   

   >> Share

   
   

   
   Am J Clin Oncol

3. HASSANZADEH E, Sedighi Pashaki A, Akbari Hamed E, Mehrpooya M, et al
   Evaluating N-acetylcysteine as a Protective Agent Against Chemotherapy-induced Neuropathy in Breast Cancer: A Triple-blind, Randomized Clinical Trial.
   Am J Clin Oncol. 2024 Nov 4. doi: 10.1097/COC.0000000000001153.
   

   >> Share

   
   

   
   Am J Surg

4. LIPSYC-SHARF M, Huang M, Huang SY, Suresh YK, et al
   Impact of timing of pregnancy and genetic risk on local therapy choices for young women with breast cancer.
   Am J Surg. 2024;239:116060.
   

   >> Share

   
   
5. HIGGINS MG, Vemuru S, Helmkamp L, Adams M, et al
   Access to results of patient reported outcome surveys did not improve longitudinal patient reported outcomes in breast cancer patients in a randomized controlled trial.
   Am J Surg. 2024;239:116054.
   

   >> Share

   
   

   
   Ann Surg Oncol

6. VASIGH M, Mohamed A, Jacobs L, Lange J, et al
   ASO Visual Abstract: The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer.
   Ann Surg Oncol. 2024 Nov 5. doi: 10.1245/s10434-024-16404.
   

   >> Share

   
   

   
   BMC Cancer

7. BI Z, Cheng WH, Zheng WH, Ren TY, et al
   The optimal timing of breast cancer surgery after COVID-19 infection: an observational study.
   BMC Cancer. 2024;24:1348.
   

   >> Share

   
   

   
   Breast Cancer (Auckl)

8. TOKURA M, Ando MM, Kojima Y, Kitadai R, et al
   Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY Study.
   Breast Cancer (Auckl). 2024;18:11782234241288671.
   

   >> Share

   
   
9. GIANNOUDIS A, Heath A, Sharma V
   ENO1 as a Biomarker of Breast Cancer Progression and Metastasis: A Bioinformatic Approach Using Available Databases.
   Breast Cancer (Auckl). 2024;18:11782234241285648.
   

   >> Share

   
   

   
   Breast Cancer (Dove Med Press)

10. GOEL PN, Katsumata M, Qian W, Mathur S, et al
    Targeting erbB Pathways in Breast Cancer: Dual Kinase Inhibition for Brain Metastasis and Prevention of p185HER2/Neu Tumor Development.
    Breast Cancer (Dove Med Press). 2024;16:725-733.
    

    >> Share

    
    

    
    Breast Cancer Res

11. MANOUCHEHRI JM, Datta J, Marcho LM, Reardon JJ, et al
    The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer.
    Breast Cancer Res. 2024;26:153.
    

    >> Share

    
    
12. ZUO X, Zhao X, Zhang X, Li Q, et al
    PTPN20 promotes metastasis through activating NF-kappaB signaling in triple-negative breast cancer.
    Breast Cancer Res. 2024;26:155.
    

    >> Share

    
    
13. KOOK Y, Lee YJ, Chu C, Jang JS, et al
    Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 h + HER2- breast cancer: a retrospective analysis.
    Breast Cancer Res. 2024;26:154.
    

    >> Share

    
    
14. LEE YJ, Noh WC, Gwark S, Kim HA, et al
    Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy: an ASTRRA Substudy.
    Breast Cancer Res. 2024;26:152.
    

    >> Share

    
    
15. BUSUND M, Ursin G, Lund E, Chen SLF, et al
    Menopausal hormone therapy and incidence, mortality, and survival of breast cancer subtypes: a prospective cohort study.
    Breast Cancer Res. 2024;26:151.
    

    >> Share

    
    
16. CHRISTENSEN MH, Vinter CA, Olesen TB, Petersen MH, et al
    Breast cancer in women with previous gestational diabetes: a nationwide register-based cohort study.
    Breast Cancer Res. 2024;26:150.
    

    >> Share

    
    

    
    Breast Cancer Res Treat

17. CHIEN YN, Lin LY, Lin YC, Hsieh YC, et al
    Taxane/anthracycline combinations reduced incidence of breast cancer recurrence in young women across molecular subtypes: a real-world evidence of Taiwan from 2011 to 2019.
    Breast Cancer Res Treat. 2024 Nov 2. doi: 10.1007/s10549-024-07527.
    

    >> Share

    
    
18. XING N, Liu D, Chen L, Wang G, et al
    Quantitative analysis of pressure levels in manual lymphatic drainage across stages of breast cancer-related lymphedema: implications for optimized treatment protocols.
    Breast Cancer Res Treat. 2024 Nov 4. doi: 10.1007/s10549-024-07540.
    

    >> Share

    
    
19. VADLAKONDA A, Chervu NL, Porter G, Sakowitz S, et al
    Racial disparities in presenting stage and surgical management among octogenarians with breast cancer: a national cancer database analysis.
    Breast Cancer Res Treat. 2024 Nov 4. doi: 10.1007/s10549-024-07531.
    

    >> Share

    
    
20. PISLAR N, Gasljevic G, Matos E, Pilko G, et al
    Predicting nodal response to neoadjuvant treatment in breast cancer with core biopsy biomarkers of tumor microenvironment using data mining.
    Breast Cancer Res Treat. 2024 Nov 4. doi: 10.1007/s10549-024-07539.
    

    >> Share

    
    

    
    Cancer Epidemiol Biomarkers Prev

21. CURRO II, Teasdale CA, Wyatt LC, Foster V, et al
    Cancer Screening, Knowledge, and Fatalism among Chinese, Korean, and South Asian Residents of New York City.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1475-1483.
    

    >> Share

    
    

    
    Clin Breast Cancer

22. WANG H, Cao Y, Zhang L, Zhao Q, et al
    RBM15 Drives Breast Cancer Cell Progression and Immune Escape via m6A-Dependent Stabilization of KPNA2 mRNA.
    Clin Breast Cancer. 2024 Sep 26:S1526-8209(24)00265.
    

    >> Share

    
    
23. LI X, Yan C, Yun J, Xu X, et al
    USP4/CARM1 Axis Promotes the Malignant Transformation of Breast Cancer Cells by Upregulating SLC7A11 Expression.
    Clin Breast Cancer. 2024 Oct 16:S1526-8209(24)00280.
    

    >> Share

    
    

    
    Clin Med Insights Oncol

24. IBRAHIM AO, Omonijo A, Agbesanwa TA, Alabi AK, et al
    A 14-Year Analysis of Breast Cancer Risk Factors and Its Determinants of Mortality in Rural Southwestern Nigeria.
    Clin Med Insights Oncol. 2024;18:11795549241288197.
    

    >> Share

    
    

    
    Eur J Cancer

25. ANKERSMID JW, Drossaert CHC, Strobbe LJA, Hackert MQN, et al
    Shared decision-making supported by outcome information regarding surveillance after curative treatment for breast cancer: Results of the SHOUT-BC study.
    Eur J Cancer. 2024;213:115107.
    

    >> Share

    
    
26. VALENZA C, Trapani D, Zagami P, Antonarelli G, et al
    Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study.
    Eur J Cancer. 2024;213:115097.
    

    >> Share

    
    
27. VAN OMMEN-NIJHOF A, Steenbruggen TG, Wiersma TG, Balduzzi S, et al
    Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Primary outcomes from the randomized phase III OLIGO study.
    Eur J Cancer. 2024;213:115083.
    

    >> Share

    
    

    
    Eur J Surg Oncol

28. ALLOTEY J, Ruparel V, McCallum A, Somal K, et al
    Residual microcalcifications after neoadjuvant systemic therapy for early breast cancer: Implications for surgical planning and long-term outcomes.
    Eur J Surg Oncol. 2024;51:108781.
    

    >> Share

    
    
29. PARK WK, Kim HJ, Ryu JM, Chae BJ, et al
    Evaluating the feasibility of repeat sentinel lymph node biopsy in ipsilateral breast tumor recurrence: Technical considerations and oncologic outcomes.
    Eur J Surg Oncol. 2024;50:108644.
    

    >> Share

    
    

    
    Gene

30. TAN SY, Foo CN, Ng FL, Tan CH, et al
    Gene expression Profiling of maslinic Acid-treated MCF-7 breast cancer cells using Nanostring nCounter Pancancer pathway Panel.
    Gene. 2024 Oct 30:149043. doi: 10.1016/j.gene.2024.149043.
    

    >> Share

    
    

    
    Histopathology

31. HEMPENIUS MA, Eenkhoorn MA, Hoeg H, Dabbs DJ, et al
    Quantitative comparison of immunohistochemical HER2-low detection in an interlaboratory study.
    Histopathology. 2024;85:920-928.
    

    >> Share

    
    

    
    Int J Cancer

32. SCHEI-ANDERSEN AJ, Hendricks LAJ, van der Post RS, Mensenkamp AR, et al
    Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single-center study.
    Int J Cancer. 2024;155:1567-1576.
    

    >> Share

    
    
33. CAO L, Ou D, Qi WX, Xu C, et al
    A randomized trial of early cardiotoxicity in breast cancer patients receiving postoperative IMRT with or without serial cardiac dose constraints.
    Int J Cancer. 2024 Nov 5. doi: 10.1002/ijc.35245.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

34. REDDY JP, Sherry AD, Fellman B, Liu S, et al
    Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): a Multicenter, Randomized Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2024 Oct 30:S0360-3016(24)03522.
    

    >> Share

    
    

    
    J Biol Chem

35. THI K, Del Toro K, Licon-Munoz Y, Sayaman RW, et al
    Comprehensive identification, isolation, and culture of human breast cell types.
    J Biol Chem. 2024;300:107637.
    

    >> Share

    
    

    
    J Clin Oncol

36. GRINDA T, Burstein HJ
    Anthracyclines in Early Breast Cancer: The Long Goodbye.
    J Clin Oncol. 2024 Nov 5:JCO2401916. doi: 10.1200/JCO-24-01916.
    

    >> Share

    
    

    
    Nat Rev Clin Oncol

37. DRAGO J, Modi S
    Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now?
    Nat Rev Clin Oncol. 2024 Nov 6. doi: 10.1038/s41571-024-00963.
    

    >> Share

    
    

    
    Oncogene

38. NING W, Yang J, Ni R, Yin Q, et al
    Hypoxia induced cellular and exosomal RPPH1 promotes breast cancer angiogenesis and metastasis through stabilizing the IGF2BP2/FGFR2 axis.
    Oncogene. 2024 Nov 4. doi: 10.1038/s41388-024-03213.
    

    >> Share

    
    

    
    PLoS Biol

39. DEL TORO K, Sayaman R, Thi K, Licon-Munoz Y, et al
    Transcriptomic analysis of the 12 major human breast cell types reveals mechanisms of cell and tissue function.
    PLoS Biol. 2024;22:e3002820.
    

    >> Share

    
    

    
    PLoS One

40. SILVA MA, Williams S, Hauert S, Ovadia B, et al
    Tumour assessment of ROR1 levels in various adult leukaemia and lymphoma types.
    PLoS One. 2024;19:e0313026.
    

    >> Share

    
    
41. TIBENDERANA JR, Kessy SA, Mlaponi DF, Mwaitete NL, et al
    Predictors of breast cancer screening among women of reproductive age in Tanzania: Evidence from DHS 2022.
    PLoS One. 2024;19:e0298996.
    

    >> Share

    
    
42. ZHANG H, Liang H, Wenjia G, Jing M, et al
    ACL-DUNet: A tumor segmentation method based on multiple attention and densely connected breast ultrasound images.
    PLoS One. 2024;19:e0307916.
    

    >> Share

    
    

    
    Radiol Artif Intell

43. STOWERS CE, Wu C, Xu Z, Kumar S, et al
    Combining Biology-based and MRI Data-driven Modeling to Predict Response to Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
    Radiol Artif Intell. 2024 Nov 6:e240124. doi: 10.1148/ryai.240124.
    

    >> Share

    
    

    
    Radiology

44. HA SM, Choi WJ, Han BK, Kim HH, et al
    Assessment of Nonmass Lesions Detected with Screening Breast US Based on Mammographic Findings.
    Radiology. 2024;313:e240043.
    

    >> Share

    
    

    
    Radiother Oncol

45. SMINE Z, Poeta S, De Caluwe A, Desmet A, et al
    Automated segmentation in planning-CT for breast cancer radiotherapy: A review of recent advances.
    Radiother Oncol. 2024;202:110615.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share